<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-title>Lipids in Health and Disease</journal-title><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15271218</article-id><article-id pub-id-type="pmc">PMC497049</article-id><article-id pub-id-type="publisher-id">1476-511X-3-18</article-id><article-id pub-id-type="doi">10.1186/1476-511X-3-18</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Low fasting low high-density lipoprotein and postprandial lipemia</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Kolovou</surname><given-names>Genovefa D</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>genkolovou@mail.gr</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Anagnostopoulou</surname><given-names>Katherine K</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kat_anag@yahoo.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Pilatis</surname><given-names>Nektarios</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>nekpil@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kafaltis</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>genkolovou@mail.gr</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Sorodila</surname><given-names>Konstandina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>genkolovou@mail.gr</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Psarros</surname><given-names>Eleftherios</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>genkolovou@mail.gr</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Cokkinos</surname><given-names>Dennis V</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cokkino1@otenet.gr</email></contrib></contrib-group><aff id="I1"><label>1</label>1<sup>st </sup>Cardiology Department, Onassis Cardiac Surgery Center, 17674, Athens, Greece</aff><aff id="I2"><label>2</label>Biochemistry Laboratory, Onassis Cardiac Surgery Center, 17674, Athens, Greece</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>23</day><month>7</month><year>2004</year></pub-date><volume>3</volume><fpage>18</fpage><lpage>18</lpage><ext-link ext-link-type="uri" xlink:href="http://www.lipidworld.com/content/3/1/18"/><history><date date-type="received"><day>21</day><month>6</month><year>2004</year></date><date date-type="accepted"><day>23</day><month>7</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Kolovou et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Kolovou et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Kolovou
               D
               Genovefa
               
               genkolovou@mail.gr
            </dc:author><dc:title>
            Low fasting low high-density lipoprotein and postprandial lipemia
         </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>Lipids in Health and Disease 3(1): 18-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-511X(2004)3:1&#x0003c;18&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-511X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Low levels of high density lipoprotein (HDL) cholesterol and disturbed postprandial lipemia are associated with coronary heart disease. In the present study, we evaluated the variation of triglyceride (TG) postprandially in respect to serum HDL cholesterol levels.</p></sec><sec><title>Results</title><p>Fifty two Greek men were divided into 2 main groups: a) the low HDL group (HDL &#x0003c; 40 mg/dl), and b) the control group. Both groups were further matched according to fasting TG (matched-low HDL, and matched-control groups). The fasting TG concentrations were higher in the low HDL group compared to controls (<italic>p </italic>= 0.002). The low HDL group had significantly higher TG at 4, 6 and 8 h postprandially compared to the controls (<italic>p </italic>= 0.006, <italic>p </italic>= 0.002, and <italic>p </italic>&#x0003c; 0.001, respectively). The matched-low HDL group revealed higher TG only at 8 h postprandially (<italic>p </italic>= 0.017) compared to the matched-control group. ROC analysis showed that fasting TG &#x02265; 121 mg/dl have 100% sensitivity and 81% specificity for an abnormal TG response (auc = 0.962, <italic>p </italic>&#x0003c; 0.001).</p></sec><sec><title>Conclusions</title><p>The delayed TG clearance postprandially seems to result in low HDL cholesterol even in subjects with low fasting TG. The fasting TG &#x0003e; 121 mg/dl are predictable for abnormal response to fatty meal.</p></sec></abstract><kwd-group><kwd>low high-density lipoprotein cholesterol</kwd><kwd>coronary heart disease</kwd><kwd>postprandial lipemia</kwd><kwd>triglyceride clearance.</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>The hypothesis that low levels of high density lipoprotein (HDL) cholesterol is associated with coronary heart disease (CHD), raised since the 1950s [<xref ref-type="bibr" rid="B1">1</xref>]. Fifty years later, it was well-established [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] as it has been excellently proved after a number of large prospective studies [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. In the PROCAM Study [<xref ref-type="bibr" rid="B6">6</xref>] 45% of men and women who developed CHD had an HDL cholesterol lower than 35 mg/dl. In the Framingham Heart Study, total cholesterol levels did not provide a predictive value in identifying people at risk for CHD compared to cholesterol/HDL ratio [<xref ref-type="bibr" rid="B7">7</xref>]. Furthermore, a change in ratio is better predictor for successful CHD risk reduction than changes in total cholesterol levels. There is no longer any doubt that HDL cholesterol is a powerful independent inverse predictor of CHD. On the other hand, the long duration of the postprandial lipemia and repetition of meals during the daytime leads to important changes of lipoproteins postprandially. Studies have shown that disturbed postprandial lipemia is found in patients with CHD [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>] and other conditions [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>] related to an increased risk of cardiovascular disease. Many studies comparing patients with CHD and controls have shown that postprandial triglyceride (TG) levels were an independent predictor of CHD in multivariate analysis [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. In the present study, we evaluated the variation of TG postprandially in respect to serum HDL cholesterol levels. The delayed TG clearance postprandially seems to result in low HDL cholesterol even in subjects with low fasting TG.</p></sec><sec><title>Results</title><p>All participants ingested their fatty meal and tolerated it well.</p><sec><title>Baseline characteristics (Table <xref ref-type="table" rid="T1">1</xref>)</title><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Clinical characteristics of the two main study groups (all low HDL patients and controls). All biochemical values were obtained in the fasting state and for TG 4,6,8 h postprandially.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Characteristics</td><td align="center">Low HDL n = 29</td><td align="center">Controls n = 23</td><td align="left">P values</td></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="center">45(13)</td><td align="center">51(9)</td><td align="left">NS</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">26(2)</td><td align="center">26(3)</td><td align="left">NS</td></tr><tr><td align="left">CHD -/+</td><td align="center">19/10</td><td align="center">23/0</td><td align="left">0.002</td></tr><tr><td align="left">Hypertension-/+</td><td align="center">27/2</td><td align="center">23/0</td><td align="left">NS</td></tr><tr><td align="left">Smokers-/+</td><td align="center">17/12</td><td align="center">23/0</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">Diabetes mellitus</td><td align="center">28/1</td><td align="center">23/0</td><td align="left">NS</td></tr><tr><td align="left">TC (mg/dl)</td><td align="center">198(45)</td><td align="center">194(38)</td><td align="left">NS</td></tr><tr><td align="left">HDL (mg/dl)</td><td align="center">31(7)</td><td align="center">53(19)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">LDL (mg/dl)</td><td align="center">141(39)</td><td align="center">124(38)</td><td align="left">NS</td></tr><tr><td align="left">Apo A (mg/dl)</td><td align="center">123(28)</td><td align="center">153(42)</td><td align="left">0.007</td></tr><tr><td align="left">Apo B (mg/dl)</td><td align="center">127(56)</td><td align="center">126(30)</td><td align="left">NS</td></tr><tr><td align="left">Lp (a) (mg/dl)</td><td align="center">25(25)</td><td align="center">30(29)</td><td align="left">NS</td></tr><tr><td align="left">Glucose (mg/dl)</td><td align="center">94(13)</td><td align="center">90(11)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>0 </sub>(mg/dl)</td><td align="center">128(54)</td><td align="center">89(30)</td><td align="left">0.002</td></tr><tr><td align="left">TG<sub>4 </sub>(mg/dl)</td><td align="center">207(102)</td><td align="center">140(36)</td><td align="left">0.006</td></tr><tr><td align="left">TG<sub>6 </sub>(mg/dl)</td><td align="center">210(112)</td><td align="center">135(45)</td><td align="left">0.002</td></tr><tr><td align="left">TG<sub>8 </sub>(mg/dl)</td><td align="center">192(92)</td><td align="center">103(37)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">AUC (mg/dl/h)</td><td align="center">1459(631)</td><td align="center">1007(253)</td><td align="left">&#x0003c;0.005</td></tr></tbody></table><table-wrap-foot><p>All values are presented as means (standard deviation). BMI: body mass index, CHD: coronary heart disease, TC: total cholesterol, HDL: high-density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG<sub>0</sub>: fasting plasma triglyceride concentration, TG<sub>4, </sub>TG<sub>6, </sub>TG<sub>8</sub>: plasma triglyceride concentration 4,6,8 h after the fat load, respectively, AUC: area under the curve. For TC, HDL and LDL, to convert from mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to mmol/L divide by 88.6</p></table-wrap-foot></table-wrap><p>The clinical characteristics of the two main study groups (low HDL and controls) are shown in Table <xref ref-type="table" rid="T1">1</xref>. Renal and liver function was normal as determined by measuring plasma creatinine, urea, uric acid, alanine aminotransferase, aspartate aminotransferase and &#x003b3;-glutamate transferase. Therefore, there was no biochemical evidence of a fatty liver. Baseline glucose levels were similar in both groups. None of the patients fulfilled the criteria for the metabolic syndrome according to the National Cholesterol Education Program- Adults Treatment Panel III (NCEP ATP III) guidelines [<xref ref-type="bibr" rid="B14">14</xref>].</p><p>The plasma HDL cholesterol and apolipoprotein A were lower in low HDL group compared to controls (<italic>p </italic>&#x0003c; 0.001, and <italic>p </italic>= 0.007, respectively) by definition. The fasting TG (TG<sub>0</sub>) concentrations were higher in low HDL cholesterol group compared to controls (<italic>p </italic>= 0.002).</p></sec><sec><title>Postprandial TG concentrations in the two main groups (low HDL subjects and controls) (Table <xref ref-type="table" rid="T1">1</xref>, Figure <xref ref-type="fig" rid="F1">1</xref>)</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Schematic representation of TG-AUC of all groups in relation to time. The highest AUC values were observed in low HDL and low HDL-A groups which are characterized by low fasting HDL levels and the highest fasting TG levels compared to the other groups. The lowest AUC values were found in matched-low HDL, matched-controls, low HDL-N and control groups. These are characterized by lower fasting TG levels but with variable fasting HDL levels, ranging from 30(9) to 55(20) mg/dl. This means that the primary determinant of the magnitude of TG postprandial response is the fasting TG concentration. TG-AUC: triglyceride-area under the curve Low HDL-A: low HDL-Abnormal group Low HDL-N: low HDL-Normal group</p></caption><graphic xlink:href="1476-511X-3-18-1"/></fig><sec><title>TG levels 4 h after the fatty meal (TG<sub>4</sub>)</title><p>The low HDL subjects had a significantly higher (<italic>p </italic>&#x0003c; 0.006) TG level compared to the controls.</p></sec><sec><title>TG levels 6 h after the fatty meal (TG<sub>6</sub>)</title><p>The low HDL subjects had a significantly higher (<italic>p </italic>&#x0003c; 0.002) TG level compared to controls.</p></sec><sec><title>TG levels 8 h after the fatty meal (TG<sub>8</sub>)</title><p>The low HDL subjects had a significantly higher (<italic>p </italic>&#x0003c; 0.001) TG level compared to the controls.</p><p>Glucose did not show any change postprandially.</p><p>The above groups were subdivided in matched-low HDL and matched-control group (matched for low fasting TG levels) and in low HDL-Abnormal (low HDL-A) and low HDL-Normal (low HDL-N) groups (based on their TG postprandial response).</p></sec></sec><sec><title>Results of the matched low HDL subjects and matched controls (Table <xref ref-type="table" rid="T2">2</xref>, Figure <xref ref-type="fig" rid="F1">1</xref>)</title><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Clinical characteristics and biochemical parameters of the low HDL subjects matched to controls for fasting TG levels, and their response to a fatty meal.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Characteristics</td><td align="center">Matched-low HDL n = 20</td><td align="center">Matched-controls n = 20</td><td align="left">P values</td></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="center">47(13)</td><td align="center">51(10)</td><td align="left">NS</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">26(2)</td><td align="center">25(2)</td><td align="left">NS</td></tr><tr><td align="left">CHD -/+</td><td align="center">11/9</td><td align="center">20/0</td><td align="left">0.001</td></tr><tr><td align="left">Hypertension-/+</td><td align="center">18/2</td><td align="center">20/0</td><td align="left">NS</td></tr><tr><td align="left">Smokers-/+</td><td align="center">13/7</td><td align="center">20/0</td><td align="left">0.004</td></tr><tr><td align="left">TC (mg/dl)</td><td align="center">187(50)</td><td align="center">197(35)</td><td align="left">NS</td></tr><tr><td align="left">HDL (mg/dl</td><td align="center">31(8)</td><td align="center">55(20)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">LDL (mg/dl)</td><td align="center">136(43)</td><td align="center">128(38)</td><td align="left">NS</td></tr><tr><td align="left">Apo A (mg/dl)</td><td align="center">123(31)</td><td align="center">158(43)</td><td align="left">0.009</td></tr><tr><td align="left">Apo B (mg/dl)</td><td align="center">123(63)</td><td align="center">132(27)</td><td align="left">NS</td></tr><tr><td align="left">Lp (a) (mg/dl)</td><td align="center">29(27)</td><td align="center">28(23)</td><td align="left">NS</td></tr><tr><td align="left">Glucose (mg/dl)</td><td align="center">95(14)</td><td align="center">90(11)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>0 </sub>(mg/dl)</td><td align="center">100(31)</td><td align="center">95(27)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>4 </sub>(mg/dl)</td><td align="center">153(55)</td><td align="center">140(36)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>6 </sub>(mg/dl)</td><td align="center">172(105)</td><td align="center">138(45)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>8 </sub>(mg/dl)</td><td align="center">154(78)</td><td align="center">105(38)</td><td align="left">0.017</td></tr><tr><td align="left">AUC (mg/dl/h)</td><td align="center">1142(322)</td><td align="center">1007(253)</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p>All values are presented as means (standard deviation). BMI: body mass index, CHD: coronary heart disease, TC: total cholesterol, HDL: high-density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG<sub>0</sub>: fasting plasma triglyceride concentration, TG<sub>4, </sub>TG<sub>6, </sub>TG<sub>8</sub>: plasma triglyceride concentration 4,6,8 h after the fat load, respectively, AUC: area under the curve. For TC, HDL and LDL, to convert from mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to mmol/L divide by 88.6</p></table-wrap-foot></table-wrap><p>Subjects with low HDL cholesterol had higher TG concentration at 8 h postprandially (<italic>p </italic>= 0.017).</p></sec><sec><title>Results of the low HDL subjects divided into those with (low HDL-N group) and without (low HDL-A group) a normal response to a fatty meal (Table <xref ref-type="table" rid="T3">3</xref>, Figure <xref ref-type="fig" rid="F1">1</xref>)</title><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Clinical characteristics and biochemical parameters of the low HDL subjects with an abnormal (low HDL-A) and normal response (low HDL-N) to a fatty meal.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Characteristics</td><td align="center">low HDL-A n = 13</td><td align="center">low HDL-N n = 16</td><td align="left">P values</td></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="center">42(14)</td><td align="center">48(13)</td><td align="left">NS</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">26(2)</td><td align="center">27(3)</td><td align="left">NS</td></tr><tr><td align="left">CHD-/+</td><td align="center">12/1</td><td align="center">7/9</td><td align="left">0.006</td></tr><tr><td align="left">Hypertension-/+</td><td align="center">11/2</td><td align="center">16/0</td><td align="left">NS</td></tr><tr><td align="left">Smokers-/+</td><td align="center">6/7</td><td align="center">11/5</td><td align="left">NS</td></tr><tr><td align="left">TC (mg/dl)</td><td align="center">221(16)</td><td align="center">179(53)</td><td align="left">0.007</td></tr><tr><td align="left">HDL (mg/dl)</td><td align="center">32(5)</td><td align="center">30(9)</td><td align="left">NS</td></tr><tr><td align="left">LDL (mg/dl)</td><td align="center">154(22)</td><td align="center">130(46)</td><td align="left">NS</td></tr><tr><td align="left">Apo A (mg/dl)</td><td align="center">131(18)</td><td align="center">118(31)</td><td align="left">NS</td></tr><tr><td align="left">Apo B (mg/dl)</td><td align="center">135(17)</td><td align="center">122(68)</td><td align="left">NS</td></tr><tr><td align="left">Lp (a) (mg/dl)</td><td align="center">10(7)</td><td align="center">32(28)</td><td align="left">0.012</td></tr><tr><td align="left">Glucose (mg/dl)</td><td align="center">92(11)</td><td align="center">95(14)</td><td align="left">NS</td></tr><tr><td align="left">TG<sub>0 </sub>(mg/dl)</td><td align="center">172(43)</td><td align="center">92(29)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">TG<sub>4 </sub>(mg/dl)</td><td align="center">298(82)</td><td align="center">135(35)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">TG<sub>6 </sub>(mg/dl)</td><td align="center">321(74)</td><td align="center">127(35)</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">TG<sub>8 </sub>(mg/dl)</td><td align="center">270(78)</td><td align="center">129(37)</td><td align="left">&#x0003c; 0.001</td></tr><tr><td align="left">AUC (mg/dl/h)</td><td align="center">2074(381)</td><td align="center">986(252)</td><td align="left">&#x0003c;0.012</td></tr></tbody></table><table-wrap-foot><p>All values are presented as means (standard deviation) BMI: body mass index, CHD: coronary heart disease, TC: total cholesterol, HDL: high-density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG<sub>0</sub>: fasting plasma triglyceride concentration, TG<sub>4, </sub>TG<sub>6, </sub>TG<sub>8</sub>: plasma triglyceride concentration 4,6,8 h after the fat load, respectively, AUC: area under the curve. For TC, HDL and LDL, to convert from mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to mmol/L divide by 88.6</p></table-wrap-foot></table-wrap><p>Thirteen (45%) of the low HDL subjects (low HDL-A group) had an abnormal TG response to the fatty meal test compared to the controls. The other sixteen low HDL subjects (low HDL-N group) had a TG response to the fatty meal that was similar to that in the control subjects. The low HDL subjects with an abnormal fatty meal response (low HDL-A group) had higher plasma total cholesterol and lower lipoprotein (a) concentrations (<italic>p </italic>= 0.007, and <italic>p </italic>&#x0003c; 0.012, respectively). As expected, postprandial TG levels were higher in those classified as having an abnormal response.</p><p>TG levels of all groups (low HDL, controls, matched low HDL, matched controls, low HDL-A, low HDL-N) in relation to time are schematically represented in Figure <xref ref-type="fig" rid="F1">1</xref>.</p></sec><sec><title>Predictors of abnormal TG response</title><p>In multivariate linear regression analysis, where the independent variables were age, body mass index (BMI), total cholesterol, HDL cholesterol, TG, lipoprotein (a), and areas under the curve (AUC) was the dependent variable, the TG<sub>0 </sub>was the only predictor of high AUC values (Coefficience B = 7.15, <italic>p </italic>= 0.016). ROC analysis showed that TG<sub>0 </sub>levels &#x02265; 121 mg/dl have 100% sensitivity and 81% specificity for an abnormal TG response (auc=0.962, <italic>p </italic>&#x0003c; 0.001). After we divided the low HDL men in low- or high- groups by using the ROC curve cut-off values of TG<sub>0</sub>, total cholesterol and lipoprotein (a), i.e. low/high TG<sub>0</sub>, low/high total cholesterol and low/high lipoprotein (a) groups, the only distinction that predicted an abnormal TG response was the high-TG<sub>0 </sub>group (<italic>p </italic>&#x0003c; 0.001)</p></sec></sec><sec><title>Discussion</title><p>In the present study, we found that a slower clearance of TG-rich lipoproteins from circulation postprandially results in low fasting levels of HDL cholesterol. Additionally, fasting plasma TG concentration is the primary determinant of the magnitude of postprandial lipemia.</p><p>Subjects with a low fasting HDL and low TG levels showed a delayed TG clearance at 8 h compared to those with a normal fasting HDL value. The increase in TGs (from 2 to 4 h) after meal consumption mainly reflects dietary TG absorption, whereas the return to fasting levels (from 6 to 9 h) is presumably a function of TG clearance [<xref ref-type="bibr" rid="B15">15</xref>]. In our study, the delayed response of TGs to the fatty meal in matched group for low fasting TG levels may be indicative for an HDL involvement. It has been proposed that elevated plasma TG concentrations promote the cholesterol ester exchange reactions mediated by cholesteryl ester transfer protein [<xref ref-type="bibr" rid="B16">16</xref>]. It is possible that in this transient hypertriglyceridemia, the HDL particles are TG-enriched via cholesteryl ester transfer protein mediated exchange with TG-rich lipoproteins. Such HDL-TG enriched particles are cleared more rapidly from the circulation [<xref ref-type="bibr" rid="B17">17</xref>] leading to low serum HDL cholesterol levels [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. In subjects with initially low HDL concentrations and low fasting TG levels, it is possible that this reaction does not happen at all or happens in a less degree and the slower removal of TGs from the circulation could be explained by insufficient amount of HDL particles which are responsible for their clearance.</p><p>The high TG and low HDL cholesterol phenotype has been frequently reported in "abdominal" obesity [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. Obesity is associated with a range of metabolic abnormalities including fasting and postprandial dyslipidemia. This was clearly shown in the study of Couillard et al., whose study subjects were characterised by a BMI of 32.3 &#x000b1; 4.5 kg/m<sup>2 </sup>[<xref ref-type="bibr" rid="B22">22</xref>]. Our results showed that even in slightly overweight subjects with a BMI of 26 &#x000b1; 2 kg/m<sup>2</sup>, this phenotype may provoke similar metabolic abnormalities. The HDL formation is closely associated with TG catabolism [<xref ref-type="bibr" rid="B23">23</xref>] as mentioned above. The deleterious effect of the high TG and low HDL phenotype on the rate of postprandial TG clearance has been also shown in children (mean age 14 years old) [<xref ref-type="bibr" rid="B24">24</xref>]. Patsch et al., [<xref ref-type="bibr" rid="B25">25</xref>] have proposed that low HDL cholesterol levels could result from an impaired TG lipolysis, a condition that would favour an exaggerated postprandial lipemia, in subject with hypoalphalipoproteinemia.</p><p>In our study, no difference was observed in the early postprandial TG response (absorption phase) between normolipidemic controls and men with low fasting HDL cholesterol and low fasting plasma TG concentration. In contrast, the group with low HDL cholesterol (31 &#x000b1; 7 mg/dl) and variable values of fasting TG (53&#x02013;248 mg/dl, mean value 128 &#x000b1; 54 mg/dl) revealed a higher TG curve postprandially compared to healthy subjects with moderate HDL cholesterol (53 &#x000b1; 19 mg/dl) and low fasting TG levels (89 &#x000b1; 30 mg/dl). When both groups were matched for fasting TG levels, this curve-difference was diminished, although HDL cholesterol levels remained significantly different between the two groups. When subjects with low HDL cholesterol were subdivided based on their response (normal or abnormal) to fat loading, fasting TG concentration seemed to be the critical determinant of such response. Since there are no official guidelines to determine normal postprandial TG ranges, the characterization of a TG response as "normal" or "abnormal" after fat loading was based on this report and on previous reports of ours and others. The peak TG mean value in control subjects was 139 &#x000b1; 41 mg/dl (at 6 h) [<xref ref-type="bibr" rid="B11">11</xref>], 176 &#x000b1; 17 mg/dl (at 3.5 h) [<xref ref-type="bibr" rid="B26">26</xref>], 177 mg/dl [<xref ref-type="bibr" rid="B27">27</xref>] and 186 mg/dl [<xref ref-type="bibr" rid="B28">28</xref>]. Higher TG concentrations at 4 h were reported by others, approximately 213 mg/dl and 248 mg/dl [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. Therefore, we defined an abnormal postprandial TG response to the fatty meal as any postprandial TG concentration (at 4, 6 or 8 h) higher than 219 mg/dl which was the highest TG concentration in any hour in any control individual. Subjects with abnormal postprandial lipemia had fasting TG concentration twice higher than those with normal postprandial lipemia and the TG concentration remained much higher through all tests. Additionally, the ROC analysis showed that TG<sub>0 </sub>level &#x02265; 121 mg/dl have 100% sensitivity and 81% specificity for an abnormal TG response.</p><p>Couillard et al., [<xref ref-type="bibr" rid="B22">22</xref>] reported a significant association between the magnitude of the postprandial TG response and fasting plasma HDL cholesterol concentrations. However, the subjects included in their study showed a wider range of fasting TG concentrations (44&#x02013;390 mg/dl) compared to ours (53&#x02013;248 mg/dl). In the subgroup of isolated low fasting HDL cholesterol, fasting hypertriglyceridemia was a prerequisite in order to have an exaggerated postprandial TG response [<xref ref-type="bibr" rid="B22">22</xref>]. This finding was similar to ours; an abnormal response to the fatty meal was only dependent on fasting TG concentration. Cohen and co-workers [<xref ref-type="bibr" rid="B33">33</xref>] measured plasma TG and retinyl palmitate responses to different fat meals in endurance-trained men with a wide range of plasma HDL cholesterol concentrations (36&#x02013;105 mg/dl). Their data indicated that the magnitude of postprandial lipemia is not primarily affected by the HDL cholesterol concentrations, which agrees to our results. However, they failed to show any correlation between HDL cholesterol levels and chylomicron remnant metabolism which is contradictory to our findings, although we did not directly measured chylomicron remnant particles.</p><p>Postprandial hypertriglyceridemia is not a uniform abnormality. It pathophysiologic cause is not yet known. It is possible that the response to a fatty meal is gene dependent. It has been reported that a number of gene loci, such as these of apolipoprotein E, lipoprotein lipase, apolipoprotein CIII, apolipoprotein A1, apolipoprotein A4, cholesterol ester transfer protein are related to fat load response [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. However, this gene polymorphism-dependence remains controversial, and it is more likely that the postprandial lipemia is a polygenic phenomenon, although the phenotype of the postprandial lipemia is probably one. This concept allowed us to study only the phenotypic manifestation of the postprandial lipemia, which would have immediate clinical implications. Our aim was to evaluate the postprandial response in men with isolated low fasting HDL cholesterol. Although it has been also described elsewhere that baseline TG levels impact on the postprandial response and that HDL cholesterol levels are predictors of this response, the novelty of this study lies on the fact that delayed postprandially TG clearance was observed in low HDL group and that emphasis should be given on the decrease of TG levels &#x0003c; 121 mg/dl, lower that those indicated by the NCEP ATP III guidelines.</p></sec><sec><title>Conclusions</title><p>The delayed TG clearance postprandially seems to result in low HDL cholesterol levels even in subjects with low fasting TG concentration. Moreover, fasting plasma TG levels appear to be the primary determinant of the magnitude of postprandial lipemia. The fasting TG levels higher than 121 mg/dl are predictable for abnormal response to a fatty meal. This should be taken into account for the management of patients with fasting low HDL cholesterol levels.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>The study population consisted of 52 Greek men recruited from the Lipid Clinic of Onassis Cardiac Surgery Center, Athens, Greece. Heavy drinking, liver and renal disease, diabetes mellitus, metabolic syndrome, according to the NCEP ATP III guidelines [<xref ref-type="bibr" rid="B14">14</xref>], hypothyroidism and professional sport activity were exclusion criteria. No subject took lipid lowering drugs before entering the study. Only patients with CHD (defined by angiography) were taking soluble aspirin (100 mg) and isosorbide mononitrate (40 mg). No other patient or control subject was on medication.</p><p>The study population was divided into 2 main categories:</p><p>A: The low HDL group and the control group.</p><p>1. The low HDL group consisted of 29 men, mean age 45(13) years with low HDL cholesterol (&#x0003c; 40 mg/dl) according to NCEP ATP III guidelines [<xref ref-type="bibr" rid="B14">14</xref>].</p><p><bold>2. </bold>The control group consisted of 23 healthy men, mean age 51(9) years with no family history of premature atherosclerosis, diabetes mellitus, arterial hypertension or dyslipidemia. Their fasting TG levels were &#x0003c; 150 mg/dl, total cholesterol &#x0003c; 240 mg/dl and HDL cholesterol = 40 mg/dl. All subjects were never smokers.</p><p>B: Matched groups according to fasting TG level.</p><p>1. The matched-low HDL group consisted of 20 men, mean age 47(13) years with low HDL cholesterol and low fasting TG levels [100(31) mg/dl].</p><p>2. The matched controls consisted of 20 men, mean age 51(10) years with lasting TG levels 95(27) mg/dl.</p></sec><sec><title>Fat-rich meal protocol and blood sample</title><p>All patients were studied in the outpatient clinic between 8.00&#x02013;9.00 am after 12 hours (h) overnight fast. The fatty meal was consumed within 20 min and plasma TG concentrations were measured before and 4, 6 and 8 h after the fat load. During this 8 h period, the participants did not eat; they could only drink water and they did not smoke. Blood samples were drawn at 8:00 am (before the meal), at 12:30 pm (4 h after the meal), at 2:30 pm (6 h after the meal), and at 4:30 pm (8 h after the meal). In all samples total cholesterol, TG, HDL, apolipoprotein A and B, and lipoprotein (a) were measured. BMI was calculated as weight divided by height (expressed in kg/m<sup>2</sup>).</p><sec><title>Fatty meal</title><p>The fatty meal has been previously described [<xref ref-type="bibr" rid="B11">11</xref>]. Briefly, the fatty meal was a slight modification of that described by Patsch et al [<xref ref-type="bibr" rid="B8">8</xref>], consisting of 83.5% fat, 14.0 % carbohydrates and 2.5 % proteins. This was administered in a dose based on the patient's body surface area (350 g to 2 m<sup>2</sup>).</p></sec><sec><title>Definition of abnormal postprandial response</title><p>We defined postprandial hypertri-glyceridemia as any postprandial TG concentration (at 4, 6 or 8 h) higher than the highest TG concentration in any hour in any control individual; this TG value was 219 mg/dl.</p></sec><sec><title>Determination of blood lipids and glucose</title><p>Plasma total cholesterol, TG and HDL cholesterol were measured using enzymatic colorimetric methods on a Roche Integra Biochemical analyzer with commercially available kits (Roche). The serum low-density lipoprotein cholesterol levels were calculated using the Friedewald formula [<xref ref-type="bibr" rid="B36">36</xref>]. Apolipoprotein A, B and Lipoprotein (a) were measured by nephelometery (Nephelometer:BN-100, Behring, Germany). Blood glucose was measured by the hexokinase method with a Dade Behring reagent on a Dimension (Dade Behring) instrument. All samples were analyzed within 24 h.</p><p>All participants gave their informed consent before the study. The ethical committee of the Onassis Cardiac Surgery Center approved the study.</p></sec></sec><sec><title>Statistical analysis</title><p>Values of numerical characteristics were tested for normality and are presented as mean value with one standard deviation, when normally distributed, or as median and range, when they deviated from normality. A t-test for independent samples or a Mann Whitney U test was used for the comparison of numerical values between two groups and ANOVA or Kruskal-Wallis test for three groups, with Bonferoni correction for post hoc analysis. The comparison of clinical categorical variables was performed with the use of chi-square test. Multivariate linear regression analysis was performed to determine the predictors of elevated AUC levels, where age, BMI, total cholesterol, HDL cholesterol, fasting TG (TG<sub>0</sub>), and lipoprotein (a) were the independent variables tested. ROC curve statistics was used to estimate the cutoff value of baseline triglyceride, cholesterol and lipoprotein (a) levels (which they were significant univariate predictors of elevated TG levels postprandially) above which the low HDL men develop an abnormal TG response to fat load. Using those cut-off values, we created dichotomous variables for each one of the univariate predictors to test their significance in discriminating patients with abnormal TG response to fat load. The level of significance was set at <italic>p </italic>&#x0003c; 0.05. AUC for serial measurements of TG levels at baseline and after the fatty meal were calculated using the trapezoid rule.</p></sec></sec><sec><title>Authors' contributions</title><p>GK conceived the study and participated in the development of the hypothesis, the study design and drafting of the manuscript.</p><p>KA is a research associate who participated in the development of the hypothesis, study design and drafting of the manuscript.</p><p>NP participated in data analysis and in the interpretation of the findings.</p><p>NK is a physician who participated in the study design and recruitment of subjects, clinical evaluation and collection of blood samples.</p><p>KS is a senior nurse who participated in the study design, in the recruitment of subjects and in blood sample collection.</p><p>EP is a biochemist who participated in the laboratory part of the study.</p><p>DC participated in the design of the study and its coordination.</p></sec></body><back><ack><sec><title>Acknowledgment</title><p>We are grateful to Alexandra Valaora, dietician, for expertly managing the patients during the meal.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>DP</given-names></name><name><surname>Russ</surname><given-names>EM</given-names></name><name><surname>Eder</surname><given-names>HA</given-names></name></person-group><article-title>Protein-lipid relationships in human plasma</article-title><source>Am J Med</source><year>1951</year><volume>11</volume><fpage>480</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">14885223</pub-id><pub-id pub-id-type="doi">10.1016/0002-9343(51)90183-0</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaari</surname><given-names>S</given-names></name><name><surname>Goldbourt</surname><given-names/></name><name><surname>Even-Zohar</surname><given-names>S</given-names></name><name><surname>Neufeld</surname><given-names>HN</given-names></name></person-group><article-title>Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men</article-title><source>Lancet</source><year>1981</year><volume>1</volume><fpage>1011</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">6112410</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(81)92184-X</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>DJ</given-names></name><name><surname>Probstfield</surname><given-names>JL</given-names></name><name><surname>Garrison</surname><given-names>RJ</given-names></name><name><surname>Neaton</surname><given-names>JD</given-names></name><name><surname>Castelli</surname><given-names>WP</given-names></name><name><surname>Knoke</surname><given-names>JD</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Bangdiwala</surname><given-names>S</given-names></name><name><surname>Tyroler</surname><given-names>HA</given-names></name></person-group><article-title>High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies</article-title><source>Circulation</source><year>1989</year><volume>79</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">2642759</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gofman</surname><given-names>JW</given-names></name><name><surname>Young</surname><given-names>W</given-names></name><name><surname>Tandy</surname><given-names>R</given-names></name></person-group><article-title>Ischemic heart disease, atherosclerosis, and longevity</article-title><source>Circulation</source><year>1966</year><volume>34</volume><fpage>679</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">5921763</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>RC</given-names></name><name><surname>Millns</surname><given-names>H</given-names></name><name><surname>Neil</surname><given-names>HA</given-names></name><name><surname>Stratton</surname><given-names>IM</given-names></name><name><surname>Manley</surname><given-names>SE</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Holman</surname><given-names>RR</given-names></name></person-group><article-title>Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)</article-title><source>BMJ</source><year>1998</year><volume>316</volume><fpage>823</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">9549452</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Assmann</surname><given-names>G</given-names></name><name><surname>Schulte</surname><given-names>H</given-names></name></person-group><article-title>Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study</article-title><source>Am J Cardiol</source><year>1992</year><volume>70</volume><fpage>733</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">1519522</pub-id><pub-id pub-id-type="doi">10.1016/0002-9149(92)90550-I</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>S</given-names></name><name><surname>Glick</surname><given-names>H</given-names></name><name><surname>Criqui</surname><given-names>M</given-names></name><name><surname>Horowitz</surname><given-names>D</given-names></name><name><surname>Lipsitz</surname><given-names>SR</given-names></name><name><surname>Kinosian</surname><given-names>B</given-names></name></person-group><article-title>Cholesterol measures to identify and treat individuals at risk for coronary heart disease</article-title><source>Am J Prev Med</source><year>2003</year><volume>25</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">12818310</pub-id><pub-id pub-id-type="doi">10.1016/S0749-3797(03)00092-8</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patsch</surname><given-names>JR</given-names></name><name><surname>Miesenbock</surname><given-names>G</given-names></name><name><surname>Hopferwieser</surname><given-names>T</given-names></name><name><surname>Muhlberger</surname><given-names>V</given-names></name><name><surname>Knapp</surname><given-names>E</given-names></name><name><surname>Dunn</surname><given-names>JK</given-names></name><name><surname>Gotto</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Patsch</surname><given-names>W</given-names></name></person-group><article-title>Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state</article-title><source>Arterioscler Thromb</source><year>1992</year><volume>12</volume><fpage>1336</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">1420093</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Przybycien</surname><given-names>K</given-names></name><name><surname>Kornacewicz-Jach</surname><given-names>Z</given-names></name><name><surname>Torbus-Lisiecka</surname><given-names>B</given-names></name><name><surname>Naruszewicz</surname><given-names>M</given-names></name></person-group><article-title>Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol?</article-title><source>Coron Artery Dis</source><year>2000</year><volume>11</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">10895403</pub-id><pub-id pub-id-type="doi">10.1097/00019501-200007000-00001</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharrett</surname><given-names>AR</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Chambless</surname><given-names>LE</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Coady</surname><given-names>SA</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Patsch</surname><given-names/></name></person-group><article-title>Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2001</year><volume>21</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">11156865</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolovou</surname><given-names>GD</given-names></name><name><surname>Daskalova</surname><given-names>DCh</given-names></name><name><surname>Iraklianou</surname><given-names>SA</given-names></name><name><surname>Adamopoulou</surname><given-names>EN</given-names></name><name><surname>Pilatis</surname><given-names>ND</given-names></name><name><surname>Hatzigeorgiou</surname><given-names>GC</given-names></name><name><surname>Cokkinos</surname><given-names>DV</given-names></name></person-group><article-title>Postprandial lipemia in hypertension</article-title><source>J Am Coll Nutr</source><year>2003</year><volume>22</volume><fpage>80</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">12569118</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolovou</surname><given-names>G</given-names></name><name><surname>Daskalova</surname><given-names>D</given-names></name><name><surname>Anagnostopoulou</surname><given-names>K</given-names></name><name><surname>Hoursalas</surname><given-names>I</given-names></name><name><surname>Voudris</surname><given-names>V</given-names></name><name><surname>Mikhailidis</surname><given-names>DP</given-names></name><name><surname>Cokkinos</surname><given-names>DV</given-names></name></person-group><article-title>Postprandial hypertriglyceridaemia in patients with Tangier disease</article-title><source>J Clin Pathol</source><year>2003</year><volume>56</volume><fpage>937</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">14645354</pub-id><pub-id pub-id-type="doi">10.1136/jcp.56.12.937</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>MS</given-names></name><name><surname>Grosskopf</surname><given-names>I</given-names></name><name><surname>Rassin</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>H</given-names></name><name><surname>Charach</surname><given-names>G</given-names></name><name><surname>Rotmensch</surname><given-names>HH</given-names></name><name><surname>Liron</surname><given-names>M</given-names></name><name><surname>Rubinstein</surname><given-names>A</given-names></name><name><surname>Iaina</surname><given-names>A</given-names></name></person-group><article-title>Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years</article-title><source>BMJ</source><year>1996</year><volume>312</volume><fpage>936</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">8616304</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><article-title>Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III)</article-title><source>JAMA</source><year>2001</year><volume>285</volume><fpage>2486</fpage><lpage>2509</lpage><pub-id pub-id-type="pmid">11368702</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergeron</surname><given-names>N</given-names></name><name><surname>Havel</surname><given-names>RJ</given-names></name></person-group><article-title>Assessment of postprandial lipemia: nutritional influences</article-title><source>Curr Opin Lipidol</source><year>1997</year><volume>8</volume><fpage>43</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">9127711</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>DJ</given-names></name><name><surname>Caslake</surname><given-names>MJ</given-names></name><name><surname>Griffin</surname><given-names>BA</given-names></name><name><surname>Hinnie</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>CE</given-names></name><name><surname>Watson</surname><given-names>TD</given-names></name><name><surname>Packard</surname><given-names>CJ</given-names></name><name><surname>Shepherd</surname><given-names>J</given-names></name></person-group><article-title>The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma</article-title><source>Eur J Clin Invest</source><year>1998</year><volume>28</volume><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">9726040</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2362.1998.00328.x</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamarch</surname><given-names>B</given-names></name><name><surname>Rashid</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>GF</given-names></name></person-group><article-title>HDL metabolism in hepertriglyceridemic states: an overview</article-title><source>Clinica Chimica Acta</source><year>1999</year><volume>286</volume><fpage>145</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/S0009-8981(99)00098-4</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunzell</surname><given-names>JD</given-names></name><name><surname>Hokanson</surname><given-names>JE</given-names></name></person-group><article-title>Dyslipidemia of central obesity and insulin resistance</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>C10</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">10189557</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>HN</given-names></name><name><surname>Huang</surname><given-names>LS</given-names></name></person-group><article-title>The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis</article-title><source>J Cardiovasc Risk</source><year>2000</year><volume>7</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">11143762</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Despres</surname><given-names>JP</given-names></name><name><surname>Allard</surname><given-names>C</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Talbot</surname><given-names>J</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name></person-group><article-title>Evidence for a regional component of body fatness in the association with serum lipids in men and women</article-title><source>Metabolism</source><year>1985</year><volume>34</volume><fpage>967</fpage><lpage>973</lpage><pub-id pub-id-type="pmid">4046840</pub-id><pub-id pub-id-type="doi">10.1016/0026-0495(85)90147-7</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>CJ</given-names></name><name><surname>Weinsier</surname><given-names>RL</given-names></name><name><surname>Birch</surname><given-names>R</given-names></name><name><surname>Norris</surname><given-names>DJ</given-names></name><name><surname>Bernstein</surname><given-names>RS</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Pierson</surname><given-names>RN</given-names></name><name><surname>Van Itallie</surname><given-names>TB</given-names></name></person-group><article-title>Obesity and serum lipids: an evaluation of the relative contribution of body fat and fat distribution to lipid levels</article-title><source>Int J Obes</source><year>1987</year><volume>11</volume><fpage>151</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">3610468</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Couillard</surname><given-names>C</given-names></name><name><surname>Bergeron</surname><given-names>N</given-names></name><name><surname>Bergeron</surname><given-names>J</given-names></name><name><surname>Pascot</surname><given-names>A</given-names></name><name><surname>Mauriege</surname><given-names>P</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Prud'homme</surname><given-names>D</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Despres</surname><given-names>JP</given-names></name></person-group><article-title>Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations</article-title><source>J Clin Endocrinol Metab</source><year>2000</year><volume>85</volume><fpage>4575</fpage><lpage>4582</lpage><pub-id pub-id-type="pmid">11134111</pub-id><pub-id pub-id-type="doi">10.1210/jc.85.12.4575</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Intestinally-derived lipoproteins: metabolism and clinical significance</article-title><source>Diabetes Metab Rev</source><year>1991</year><volume>7</volume><fpage>191</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">1817004</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Couch</surname><given-names>SC</given-names></name><name><surname>Isasi</surname><given-names>CR</given-names></name><name><surname>Karmally</surname><given-names>W</given-names></name><name><surname>Blaner</surname><given-names>WS</given-names></name><name><surname>Starc</surname><given-names>TJ</given-names></name><name><surname>Kaluski</surname><given-names>D</given-names></name><name><surname>Deckelbaum</surname><given-names>RJ</given-names></name><name><surname>Ginsberg</surname><given-names>HN</given-names></name><name><surname>Shea</surname><given-names>S</given-names></name><name><surname>Berglund</surname><given-names>L</given-names></name></person-group><article-title>Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>72</volume><fpage>1119</fpage><lpage>1127</lpage><pub-id pub-id-type="pmid">11063438</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patsch</surname><given-names>JR</given-names></name><name><surname>Karlin</surname><given-names>JB</given-names></name><name><surname>Scott</surname><given-names>LW</given-names></name><name><surname>Smith</surname><given-names>LC</given-names></name><name><surname>Gotto</surname><given-names>AM</given-names><suffix>Jr</suffix></name></person-group><article-title>Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia</article-title><source>Proc Natl Acad Sci USA</source><year>1983</year><volume>80</volume><fpage>1449</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">6402780</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>JW</given-names></name><name><surname>Buren</surname><given-names>J</given-names></name><name><surname>Svensson</surname><given-names>M</given-names></name><name><surname>Olivecrona</surname><given-names>T</given-names></name><name><surname>Olivecrona</surname><given-names>G</given-names></name></person-group><article-title>Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects</article-title><source>Atherosclerosis</source><year>2003</year><volume>166</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">12535750</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(02)00366-0</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boquist</surname><given-names>S</given-names></name><name><surname>Ruotolo</surname><given-names>G</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Bjorkegren</surname><given-names>J</given-names></name><name><surname>Bond</surname><given-names>MG</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name></person-group><article-title>Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common intima-media thickness in healty, middle-aged men</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>723</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">10449694</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eliasson</surname><given-names>B</given-names></name><name><surname>Mero</surname><given-names>N</given-names></name><name><surname>Taskinen</surname><given-names>MR</given-names></name><name><surname>Smith</surname><given-names>U</given-names></name></person-group><article-title>The insulin resistance syndrome and postprandial lipid intolerance in smokers</article-title><source>Atherosclerosis</source><year>1997</year><volume>129</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">9069521</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(96)06028-5</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>MS</given-names></name><name><surname>Eisenberg</surname><given-names>S</given-names></name><name><surname>Breslow</surname><given-names>JL</given-names></name></person-group><article-title>Different paterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals</article-title><source>J Clin Invest</source><year>1987</year><volume>79</volume><fpage>1110</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">3470306</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabezas</surname><given-names>MC</given-names></name><name><surname>de Bruin</surname><given-names>TW</given-names></name><name><surname>Westerveld</surname><given-names>HE</given-names></name><name><surname>Meijer</surname><given-names>E</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name></person-group><article-title>Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia</article-title><source>J Inten Med</source><year>1998</year><volume>244</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2796.1998.00367.x</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Steiner</surname><given-names>G</given-names></name><name><surname>Uffelman</surname><given-names>K</given-names></name><name><surname>Olivecrona</surname><given-names>T</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name></person-group><article-title>Postprandial lipoproteins and progression of coronary atherosclerosis</article-title><source>Atherosclerosis</source><year>1994</year><volume>106</volume><fpage>83</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">8018110</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uiterwaal</surname><given-names>CS</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>van Stiphout</surname><given-names>WA</given-names></name><name><surname>Krauss</surname><given-names>XH</given-names></name><name><surname>Havekes</surname><given-names>LM</given-names></name><name><surname>de Bruijn</surname><given-names>AM</given-names></name><name><surname>van Tol</surname><given-names>A</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name></person-group><article-title>Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis</article-title><source>Ann Intern Med</source><year>1994</year><volume>121</volume><fpage>576</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">8085689</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>JC</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J</given-names></name><name><surname>Grundy</surname><given-names>SM</given-names></name></person-group><article-title>Dissociation between postprandial lipemia and high density lipoprotein cholesterol concentrations in endurance-trained men</article-title><source>Arterioscler Thromb</source><year>1991</year><volume>11</volume><fpage>838</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">2065037</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>TC</given-names></name><name><surname>Cousins</surname><given-names>M</given-names></name><name><surname>Ooi</surname><given-names>DS</given-names></name><name><surname>Steiner</surname><given-names>G</given-names></name><name><surname>Uffelman</surname><given-names>KD</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Simo</surname><given-names>IE</given-names></name></person-group><article-title>Postprandial remnant-like lipoproteins in hypertriglyceridemia</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>3134</fpage><lpage>3142</lpage><pub-id pub-id-type="pmid">11443178</pub-id><pub-id pub-id-type="doi">10.1210/jc.86.7.3134</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ordovas</surname><given-names>JM</given-names></name></person-group><article-title>Genetics, postprandial lipemia and obesity</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2001</year><volume>11</volume><fpage>118</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">11434189</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></citation></ref></ref-list></back></article>



